Sign in
Enrolling by invitationNo phase

Brain stimulation after recent spinal cord injury to help hand and arm movement

Tests magnetic brain stimulation versus sham in adults with recent spinal cord injury.

Key facts

Who runs it
Albert Einstein Healthcare Network
Where
Elkins Park, United StatesSee the site
Trial code
Registry title
NIBS Therapy in Subacute Spinal Cord Injury
Status
Enrolling by invitation
People taking part
20 people, planned
Started
9 Apr 2025
Planned end
31 May 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Active rTMS
  • sham rTMS
Record updated
30 April 2025

Who can take part

The trial is looking for adults with a recent injury to the spinal cord in the neck, with some paralysis left in the arms or hands. It tests daily magnetic brain stimulation (rTMS) against a sham (fake) stimulation.

Age
18 to 80 years old
Sex
All sexes can join
Disease stage
Cervical (neck) spinal cord injury, from trauma or other causes, less than six weeks ago. Injury level C4-C6. ASIA Impairment Scale (AIS) A-D. Some feeling and movement kept below the injury (zone of partial preservation), complete or incomplete injury.
Main reasons for not taking part
  • Needing a breathing machine (ventilator)
  • Signs of brain injury from the trauma, or another nerve condition affecting feeling or movement
  • Reasons TMS cannot be used, past seizures or seizure risk
  • Unstable spine, uncontrolled autonomic dysreflexia (sudden dangerous rise in blood pressure), or severe muscle, bone or nerve pain
  • Known or suspected pregnancy, or being medically unstable
Show the full registry criteria (15)Hide the full registry criteria

Who can take part

  • Post traumatic or non-traumatic cervical spinal cord injury (SCI) with residual upper-extremity paralysis
  • Time post-injury less than six weeks
  • Neurological Level of Injury (NLI) C4-C6
  • ASIA Impairment Scale (AIS) A-D
  • Sensory and motor zone of partial preservation (ZPP, clinically complete or incomplete)
  • Age 18 to 80 years old

Who cannot take part

  • Concurrent neurological condition affecting sensory or motor pathways or otherwise limiting ability to participate in the study
  • Contraindications for TMS or history of seizure or seizure risk
  • Ventilator dependence
  • Evidence of trauma-related brain injury
  • Spinal instability
  • Uncontrolled autonomic dysreflexia
  • Severe muscular or skeletal or neuropathic pain
  • Known or suspected pregnancy
  • Medically unstable or any reason the physician may deem as inappropriate for the participant to enroll or continue in the study

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Traumatic spinal cord injury or tetraplegia/tetraparesis

Where in United States

  • Jefferson Moss-Magee Rehabilitation - Elkins ParkElkins Park, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

No accepted clinical therapies exist for repair of motor pathways following spinal cord injury (SCI) in humans, leaving permanent disability and devastating personal and socioeconomic cost. A robust neural repair strategy has been demonstrated in preclinical studies, that is ready for translation to recovery of hand and arm function in human SCI, comprising daily transcranial magnetic stimulation treatment at the inpatient rehabilitation facility. This study will establish clinical effect size of the intervention, as well as safety and feasibility necessary for a subsequent controlled efficacy trial and inform preclinical studies for dosing optimization.

The 2 groups in the trial

  • Active rTMSExisting treatment, for comparison

    10 daily sessions of High-frequency Transcranial Magnetic Stimulation (HF-rTMS) applied bilaterally over the hand primary motor area informed by e-field modelling and targeting will be aided by neuronavigation system for precise targeting during each intervention session. Active group will receive HF-rTMS intensity calculated using electric field modelling to create electric field intensity of approximately motor threshold, using the cool-B65 A/P rTMS coil.

  • Sham rTMSSham treatment, for comparison

    10 daily sessions of Sham High-frequency Transcranial Magnetic Stimulation (HF-rTMS) applied bilaterally over the hand primary motor area informed by e-field modelling and targeting will be aided by neuronavigational system for precise targeting during each intervention session Sham group receives no active magnetic stimulation. Cool-B65 A/P rTMS coil will be used to avoid unblinding of administrator and/or study participant.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Noninvasive Brain Stimulation Therapy in Subacute Human Spinal Cord Injury: A Translational Study
Plain-language title
Brain stimulation after recent spinal cord injury to help hand and arm movementGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06247904, who can take part
Record updated
30 April 2025